Second District Affirms Denial of Nexium Marketing Class Action

by charlesjung

Eight Nexium (esomeprazole magnesium) pills, 4...
Image via Wikipedia

In Weiss v. AstraZeneca Pharmaceuticals et al., No. B215901,2010 WL 3387220 (Cal. Ct. App. 2d Dist. Aug. 30, 2010), the Second District affirmed denial of class certification and summary judgment in favor of defendants relating to the alleged deceptive marketing of the prescription drug Nexium.

By CHARLES H. JUNG

Advertisements